Zabrina L. Brumme mainly investigates Human leukocyte antigen, Immunology, Virology, Epitope and Genetics. His Human leukocyte antigen research is multidisciplinary, incorporating perspectives in Mutation and Allele. His biological study spans a wide range of topics, including Internal medicine, Chemotherapy, HIV drug resistance, Multivariate statistics and Hazard ratio.
Virology is represented through his Viral replication, Virus, Viral load, Viremia and Lentivirus research. The various areas that Zabrina L. Brumme examines in his Viral replication study include CD8, Antigen and Group-specific antigen. His Epitope research includes elements of T cell, Immune system, CTL* and HLA-B Antigens.
Zabrina L. Brumme spends much of his time researching Virology, Human leukocyte antigen, Immunology, Genetics and Immune system. His Virology research is multidisciplinary, incorporating elements of Mutation and T cell. His work in Human leukocyte antigen addresses subjects such as Epitope, which are connected to disciplines such as ELISPOT.
His study in Immune system is interdisciplinary in nature, drawing from both Adaptation and Downregulation and upregulation. His Viral replication research includes themes of Transmission, Recombinant DNA and Group-specific antigen. His Viral load study combines topics in areas such as Viral disease and Internal medicine, Disease.
His primary areas of investigation include Virology, Severe acute respiratory syndrome coronavirus 2, Viral replication, Proviral dna and Internal medicine. His Virology research is multidisciplinary, relying on both Human leukocyte antigen, Genetic variation, Downregulation and upregulation and Antiretroviral therapy. His Human leukocyte antigen study combines topics from a wide range of disciplines, such as Mutation, Viral entry, Epitope, Cytotoxic T cell and Haplotype.
His Severe acute respiratory syndrome coronavirus 2 research incorporates 2019-20 coronavirus outbreak, Viral load, Digital polymerase chain reaction, Neutralizing antibody and Immunology. Zabrina L. Brumme focuses mostly in the field of Viral replication, narrowing it down to matters related to T cell and, in some cases, In vivo. His studies deal with areas such as Nucleic acid and Human dna as well as Internal medicine.
His primary areas of study are Virology, Severe acute respiratory syndrome coronavirus 2, Internal medicine, 2019-20 coronavirus outbreak and Digital polymerase chain reaction. Zabrina L. Brumme merges Virology with Context in his research. In his works, he undertakes multidisciplinary study on Severe acute respiratory syndrome coronavirus 2 and Rapid detection.
2019-20 coronavirus outbreak is integrated with Nucleic acid, Human dna, Sample quality, Biological materials and Disease cluster in his study. Zabrina L. Brumme combines subjects such as Viral load, False Negative Reactions and Molecular marker with his study of Digital polymerase chain reaction. His research in Downregulation and upregulation intersects with topics in Tetherin, Clone, Mutagenesis, Viral pathogenesis and Viral protein.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Changes in Mitochondrial DNA as a Marker of Nucleoside Toxicity in HIV-Infected Patients
Hélène C F Côté;Zabrina L Brumme;Kevin J P Craib;Christopher S Alexander.
The New England Journal of Medicine (2002)
Predictors of HIV Drug-Resistance Mutations in a Large Antiretroviral-Naive Cohort Initiating Triple Antiretroviral Therapy
P. Richard Harrigan;Robert S. Hogg;Winnie W. Y. Dong;Benita Yip.
The Journal of Infectious Diseases (2005)
Adaptation of HIV-1 to human leukocyte antigen class I
Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews.
Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection
Matthew R. Henn;Christian L. Boutwell;Patrick Charlebois;Niall J Lennon.
PLOS Pathogens (2012)
Molecular and Clinical Epidemiology of CXCR4-Using HIV-1 in a Large Population of Antiretroviral-Naive Individuals
Zabrina L. Brumme;Zabrina L. Brumme;James Goodrich;Howard B. Mayer;Chanson J. Brumme.
The Journal of Infectious Diseases (2005)
Influence of HLA-C Expression Level on HIV Control
Richard Apps;Richard Apps;Ying Qi;Ying Qi;Jonathan M. Carlson;Haoyan Chen;Haoyan Chen.
Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8+ T Cells
Hendrik Streeck;Zabrina L Brumme;Michael P. Anastario;Kristin W Cohen.
PLOS Medicine (2008)
HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition
Toshiyuki Miura;Toshiyuki Miura;Mark A. Brockman;Arne Schneidewind;Michael Lobritz.
Journal of Virology (2009)
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor.
PLOS Medicine (2015)
TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection
Huabiao Chen;Zaza M Ndhlovu;Zaza M Ndhlovu;Dongfang Liu;Lindsay C Porter.
Nature Immunology (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: